Abbott Gets TriLipix Approval, Ensuring Lipid Lowering Franchise Beyond TriCor

 
• By Jessica Merrill

Approval bodes positively for Abbott/AstraZeneca’s joint development of a TriLipix/Crestor combination.

More from Archive

More from Pink Sheet